BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, February 24, 2026
Breaking News: BioWorld Science 2025 Year in ReviewBreaking News: Vanda gets FDA nod for atypical antipsychotic Bysanti Breaking News: Trump administration impacts continue to roil the life sciences sector
Home » Topics » BioWorld Science

BioWorld Science
BioWorld Science RSS Feed RSS

Pancreatic cancer cells.
Cancer

Pankind grant supports research into small-molecule porcupine inhibitor for pancreatic cancer

Nov. 18, 2022
An AU$300,000 grant from The Australian Pancreatic Cancer Foundation (Pankind) will support research at the Garvan Institute of Medical Research into the use of a porcupine-targeting molecule for pancreatic cancer.
Read More
Immuno-oncology

KZR-540 blocks PD-1 expression and inhibits tumor growth in vivo

Nov. 18, 2022
Preclinical studies have found that targeting...
Read More
Cancer

Kinensus designs and tests AXL/MER inhibitors

Nov. 18, 2022
The TAM family of receptor tyrosine kinases...
Read More
Immuno-oncology

Cytomx and Regeneron collaborate on conditionally activated bispecific cancer therapies

Nov. 18, 2022
Cytomx Therapeutics Inc. and Regeneron...
Read More
Brain with handshake and cityscape
Neurology/Psychiatric

Attralus and Ossianix agree to use TXP1 brain shuttle to deliver AT-04 for neurodegenerative diseases

Nov. 18, 2022
Attralus Inc. and Ossianix Inc. have entered into...
Read More
Immuno-oncology

Encouraging preclinical results reported for ASKG-915, a new cytokine prodrug fusion protein

Nov. 18, 2022
Researchers from Askgene Pharma Inc...
Read More
Liver disease
Gastrointestinal

ID-119031166 improves NASH and liver fibrosis in hamsters

Nov. 18, 2022
ID-119031166 is a non-bile acid farnesoid X...
Read More
Neurons
Neurology/Psychiatric

Intra-DRG administration of RLVT-14-02 effective against neuropathic pain in preclinical model

Nov. 18, 2022
Neuropathic pain (NP) is caused by damage or...
Read More
Cancer

No, Hippo doesn’t control normal organ growth

Nov. 18, 2022
By Mar de Miguel
It doesn't happen very often, but the same scientists who participated in the discovery of a signaling pathway can also undo their findings and go back to square one. “When we discovered Hippo signaling, some 20 years ago, everybody was excited about it because we thought it was going to explain a big part of how growth is regulated. Now it turns out that it is not what it is doing,” Georg Halder told BioWorld.


Read More
Illustration of dinosaurs with various combinations of horns and spiky backs.
Genetic/Congenital

In assessing shared genetic risk, love can look like pleiotropy

Nov. 18, 2022
By Anette Breindl
Social scientists are well aware of the consequences of what’s called assortative mating, that is, the fact that marriages tend to occur between people who are similar in things such as interests, social status, education and wealth. Biologists, on the other hand, have tended to ignore it. “When studying the genetic underpinnings of correlated traits, “for mathematical convenience, we’ve assumed basically for forever that mating is random,” Richard Border told BioWorld. “Which it isn’t.”
Read More
Previous 1 2 … 1193 1194 1195 1196 1197 1198 1199 1200 1201 … 17996 17997 Next

Popular Stories

  • Today's news in brief

    BioWorld
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • Pill in immersive interface

    New mechanism of action identified for QC-6352

    BioWorld Science
    QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
  • Illustration of brain and antibodies

    VST Bio’s VB-001 is neuroprotector after stroke

    BioWorld Science
    At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing